openPR Logo
Press release

FIT Hon Teng releases Q1 FY24 business update: turnaround in profitability in Q1 and resume growth trajectory for 2024

05-10-2024 08:43 AM CET | IT, New Media & Software

Press release from: FIT Hon Teng Limited

/ PR Agency: Think Alliance Gorup
(Hong Kong, May 10, 2024) - FIT Hon Teng Limited ("FIT", SEHK stock code: 6088) announced its unaudited first quarter business update for the three months ended March 31, 2024.

Financial Highlights:
● Revenue for the first three months of 2024 increased 12.0% to US$965.1 million
● Net profit from continuing operations reached US$10.2 million, compared to loss of US$9.3 million in corresponding period last year.

For the three months ended March 31, 2024, FIT's unaudited consolidated revenue increased by 12.0% to approximately US$965.1 million, compared to the corresponding period of last year. FIT reported an unaudited net profit from continuing operations for the three months ended March 31, 2024, of approximately US$10.2 million, compared to the unaudited net loss from continuing operations of approximately US$9.3 million in the corresponding period of last year.

The turnaround in the Group's financial performance was mainly attributable to improvement in the Group's management effectiveness and gradually recovering demand from the computing and networking end market, compared to the corresponding quarter last year.

As of March 31, 2024, our financial position remained solid with cash and cash equivalents of US$1,378.5 million, as compared to US$981.7 million for the corresponding period of last year.

Mr. Sidney Lu, Chairman and CEO, commented on FIT's performance, "We have made good progress in improving our financial performance, thanks to increased contributions from our 3+3 product portfolios and better operational efficiencies, supported by new audio product launches, robust EV mobility orders and growing demand for our next-gen AI solutions. Despite the uneven recovery in consumer electronics, we remain confident about resuming our growth trajectory for the rest of 2024."

Media Contact:
Henry Chow
Think Alliance Group
Tel: +852 3481 1161
henry.chow@think-alliance.com

No.66-1, Zhongshan St., Tucheng Dist.,
New Taipei City 236, Taiwan

About FIT Hon Teng
Foxconn Interconnect Technology (FIT) is a leading global solutions developer and manufacturer cultivating connectivity for a better world. With unsurpassed capabilities in development, research, manufacturing engineering and design, production, supply chain, and go-to-market planning for world class brands and private label products spanning B2C and B2B categories, FIT is at the forefront of worldwide technological trends delivering compelling user experiences at scale. With offices and manufacturing sites located in Asia, the Americas and Europe, FIT is a global leader in the manufacturing of high precision interconnect components. For more information, visit FIT's website: fit-foxconn.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release FIT Hon Teng releases Q1 FY24 business update: turnaround in profitability in Q1 and resume growth trajectory for 2024 here

News-ID: 3491653 • Views:

More Releases from FIT Hon Teng Limited

FIT Hon Teng Announces FY2021 Interim Results
• Revenue for the 1H 2021 amounted to US$1,982 million, representing a YoY increase of 3.4 % as compared to US$1,917 million in the same period of last year. • Interim profit attributable to owners of the Company amounted to US$9 million, representing a YoY decrease of 58.2% as compared to US$22 million in the same period of last year. • Interim Basic EPS amounted to US$0.14 cents. • The Board did not declare any interim dividend.

More Releases for US$9

US$ 9 Bn Opportunity in Global Subcutaneous Immunoglobulin Market
The global subcutaneous immunoglobulin market is projected to grow at double-digit CAGR through 2024. Demand for subcutaneous immunoglobulin products is influenced by increasing focus on treating primary immunodeficiency diseases. The healthcare infrastructure in many emerging countries has gained center stage owing to concerted efforts on part of governments. On account of these factors, the global subcutaneous immunoglobulin market is expected to reach nearly US$ 9 bn by 2024. These insights
US$ 9 Bn Opportunity in Global Subcutaneous Immunoglobulin Market
The global subcutaneous immunoglobulin market is projected to grow at double-digit CAGR through 2024. Demand for subcutaneous immunoglobulin products is influenced by increasing focus on treating primary immunodeficiency diseases. The healthcare infrastructure in many emerging countries has gained center stage owing to concerted efforts on part of governments. On account of these factors, the global subcutaneous immunoglobulin market is expected to reach nearly US$ 9 bn by 2024. These insights
Cosmetic Implants Market Worth US$ 9 Billion by 2022
New York, April 24: Market Research Engine has published a new report titled as “Cosmetic Implants Market By Type of source Analysis (Polymers, Ceramics, Metals, Biological); By Application Analysis (Breast Implants, Facial Implants, Dental Implants, Others (Buttock, Penile and Calf Implants)) and By Regional Analysis – Global Forecast by 2016 - 2022” How Big is the Global Cosmetic Implants Market? The Global Cosmetic Implants Market is expected to exceed more than
Compounding Pharmacies Market Worth US$ 9 Billion Globally by 2021
New York, February 23: Market Research Engine has published a new report titled as “Compounding Pharmacies Market By Product Segment Analysis (Oral medications, Topical medications, Mouthwashes, Suppositories), By Therapeutic Areas Analysis (Pain Medications, Hormone Replacement Therapy) – Global Industry Analysis and Forecast 2015 - 2021” How Big is the Global Compounding Pharmacies market? The Global Compounding Pharmacies market is expected to exceed more than US$ 9 Billion by 2021; Growing at a
Compounding Pharmacies Market to Exceed US$ 9 Billion by 2021
New York, February 03: Market Research Engine has published a new report titled as “Compounding Pharmacies Market By Product Segment Analysis (Oral medications, Topical medications, Mouthwashes, Suppositories), By Therapeutic Areas Analysis (Pain Medications, Hormone Replacement Therapy) – Global Industry Analysis and Forecast 2015 - 2021” How Big is the Global Compounding Pharmacies market? The Global Compounding Pharmacies market is expected to exceed more than US$ 9 Billion by 2021; Growing at a
Compounding Pharmacies Market to Reach US$ 9 Billion by 2021
New York, January 16: Market Research Engine has published a new report titled as “Compounding Pharmacies Market By Product Segment Analysis (Oral medications, Topical medications, Mouthwashes, Suppositories), By Therapeutic Areas Analysis (Pain Medications, Hormone Replacement Therapy) – Global Industry Analysis and Forecast 2015 - 2021” How Big is the Global Compounding Pharmacies market? The Global Compounding Pharmacies market is expected to exceed more than US$ 9 Billion by 2021; Growing at a